Clinical Trial

Intravenous Neonatal Central Access Safety Trial

Study acronym: INCAS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 30, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Particulate contamination due to infusion therapy (administration of parenteral nutrition and medications) carries a potential health risk for infants in neonatal intensive care units (NICU). In-line filtration is increasingly used in critically-ill infants but its benefits, by preventing micro-particle infusion in neonates, remain to be demonstrated. In-line filters in the intravenous administration sets prevent the infusion of particles, which may reduce infectious complications.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-09-09; most recent amendment 2026-03-26.
Status change: Not Yet Recruiting → Recruiting 2023-03-28
Trial Details
NCT Number NCT05537389
Lead Sponsor University of Turin, Italy
Collaborators: Pall Corporation
Conditions Newborn Complication, Catheter Complications
Enrollment 736 participants
Start Date 2023-01-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-30